Company / Operating Income
ARS Pharmaceuticals, Inc. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$179.4M
FY2025
5-year range
-$179.4M / -$3.1M
FY2021-FY2025
Trend
-5720.6%
vs FY2024
Sector context
#133 of 204
Health Care
What the data says
Operating Income changed -5721% YoY in FY2025, a notable deviation from the 5-year average annual change of -1166%.
Based on SEC 10-K filings.
-$179M in FY2025.
Declined from -$68M to -$179M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#133 of 204 in Health CareTop 65% of 204This company -$179.4M Sector average $107.7M
▼
-266.6% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 5720.6% year-over-year.
- Ranks #133 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$179.4M | -5720.6% |
| FY2024 | -$3.1M | +95.4% |
| FY2023 | -$67.5M | -247.1% |
| FY2022 | -$19.5M | +0.0% |
| FY2021 | -$19.5M | +40.9% |
| FY2020 | -$32.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026